| scholarly article | Q13442814 |
| P50 | author | Eric Viscogliosi | Q47513652 |
| Laurence Delhaes | Q114413623 | ||
| P2093 | author name string | Linh D N Nguyen | |
| P2860 | cites work | Analysis of the lung microbiome in the "healthy" smoker and in COPD | Q21091065 |
| Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis | Q21132028 | ||
| The murine lung microbiome in relation to the intestinal and vaginal bacterial communities | Q21263099 | ||
| Fungal allergy in asthma-state of the art and research needs | Q22001138 | ||
| Structure, function and diversity of the healthy human microbiome | Q24626370 | ||
| Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi | Q24630304 | ||
| The NIH Human Microbiome Project | Q24642619 | ||
| Cystic fibrosis therapy: a community ecology perspective | Q27015964 | ||
| A novel microbiota stratification system predicts future exacerbations in bronchiectasis | Q28235177 | ||
| The human mycobiome in health and disease | Q28295636 | ||
| Microbial co-occurrence relationships in the human microbiome | Q28481283 | ||
| An 8-year survey of strains identified in blood cultures in a clinical haematology unit | Q43554224 | ||
| Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients. | Q44355443 | ||
| Host-microorganism interactions in lung diseases | Q46810894 | ||
| The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis | Q51134002 | ||
| Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR. | Q54587146 | ||
| 454 Pyrosequencing Analysis of Fungal Assemblages from Geographically Distant, Disparate Soils Reveals Spatial Patterning and a Core Mycobiome | Q56989977 | ||
| The core gut microbiome, energy balance and obesity | Q57012032 | ||
| High environmental relative moldiness index during infancy as a predictor of asthma at 7 years of age | Q57215842 | ||
| Sputum Candida albicans Presages FEV 1 Decline and Hospital-Treated Exacerbations in Cystic Fibrosis | Q58817659 | ||
| Fungal respiratory infections in cystic fibrosis: a growing problem | Q82411001 | ||
| Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat | Q83391830 | ||
| Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents | Q84222220 | ||
| Reverse line blot hybridisation screening of Pseudallescheria/Scedosporium species in patients with cystic fibrosis | Q85088521 | ||
| Evaluation of the ISO standard 11063 DNA extraction procedure for assessing soil microbial abundance and community structure | Q28483669 | ||
| The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management | Q28730299 | ||
| Molecular analysis of commensal host-microbial relationships in the intestine | Q29614776 | ||
| Emerging fungal threats to animal, plant and ecosystem health | Q29616753 | ||
| Complications and associated bacterial coinfections among children hospitalized with seasonal or pandemic influenza, United States, 2003-2010. | Q30353232 | ||
| The co-pathogenesis of influenza viruses with bacteria in the lung. | Q30359731 | ||
| Metagenomic detection of phage-encoded platelet-binding factors in the human oral cavity | Q30499059 | ||
| Community-wide transcriptome of the oral microbiome in subjects with and without periodontitis | Q31152721 | ||
| Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients | Q33358120 | ||
| Characterization of the oral fungal microbiome (mycobiome) in healthy individuals | Q33523794 | ||
| Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13 | Q33557513 | ||
| Polymicrobial airway bacterial communities in adult bronchiectasis patients | Q33650443 | ||
| Enzymatic treatment of specimens before DNA extraction directly influences molecular detection of infectious agents | Q33768795 | ||
| Disordered microbial communities in the upper respiratory tract of cigarette smokers | Q33781228 | ||
| The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography | Q33901596 | ||
| Fungal-bacterial interactions and their relevance to oral health: linking the clinic and the bench | Q33965467 | ||
| Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. | Q34021561 | ||
| Comparison of six DNA extraction methods for recovery of fungal DNA as assessed by quantitative PCR. | Q34073470 | ||
| Correlation network analysis applied to complex biofilm communities | Q34098195 | ||
| Fungi and allergic lower respiratory tract diseases | Q34143534 | ||
| Defining the normal bacterial flora of the oral cavity | Q34143846 | ||
| DNA analysis of outdoor air reveals a high degree of fungal diversity, temporal variability, and genera not seen by spore morphology | Q34145090 | ||
| Infant origins of childhood asthma associated with specific molds | Q34287641 | ||
| Gut metagenome in European women with normal, impaired and diabetic glucose control | Q34347521 | ||
| Changes in cystic fibrosis airway microbiota at pulmonary exacerbation | Q34353683 | ||
| Infections in "noninfectious" lung diseases | Q34357445 | ||
| Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures | Q34388328 | ||
| Metagenomics and metatranscriptomics: windows on CF-associated viral and microbial communities | Q34404215 | ||
| Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts | Q34412019 | ||
| The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations | Q34437958 | ||
| Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis | Q34536205 | ||
| Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. | Q34577688 | ||
| The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection | Q34710850 | ||
| The emerging world of the fungal microbiome | Q34727901 | ||
| Topographic diversity of fungal and bacterial communities in human skin | Q34734628 | ||
| Asthma microbiome studies and the potential for new therapeutic strategies | Q34741123 | ||
| Asthma and the diversity of fungal spores in air. | Q34769261 | ||
| A review of nucleic acid-based diagnostic tests for systemic mycoses with an emphasis on polymerase chain reaction-based assays | Q34851810 | ||
| Adenovirus species C is associated with chronic suppurative lung diseases in children | Q35008379 | ||
| Role of yeasts in healthy and impaired gut microbiota: the gut mycome. | Q35030273 | ||
| The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes | Q35087142 | ||
| Use of denaturing high-performance liquid chromatography (DHPLC) to characterize the bacterial and fungal airway microbiota of cystic fibrosis patients. | Q35096250 | ||
| The mycobiota: interactions between commensal fungi and the host immune system. | Q35096262 | ||
| Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals | Q35113086 | ||
| Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal | Q35116209 | ||
| Differential resistance of drinking water bacterial populations to monochloramine disinfection | Q35119664 | ||
| Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi | Q35120262 | ||
| Name changes in medically important fungi and their implications for clinical practice. | Q35193147 | ||
| Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses | Q35473563 | ||
| Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis | Q35665410 | ||
| Synergistic interaction between Candida albicans and commensal oral streptococci in a novel in vitro mucosal model | Q35689554 | ||
| Case studies of the spatial heterogeneity of DNA viruses in the cystic fibrosis lung | Q35991304 | ||
| Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability | Q36152854 | ||
| Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis | Q36204582 | ||
| Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. | Q36345291 | ||
| Fungal--bacterial interactions: a mixed bag of mingling microbes | Q36507827 | ||
| Reducing bias in bacterial community analysis of lower respiratory infections | Q36702276 | ||
| Clinical and microbiological efficacy of micafungin on Geosmithia argillacea infection in a cystic fibrosis patient | Q37371983 | ||
| The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report. | Q37501328 | ||
| Role of antibiotics and fungal microbiota in driving pulmonary allergic responses | Q37521749 | ||
| Clinical insights from metagenomic analysis of sputum samples from patients with cystic fibrosis. | Q37546291 | ||
| Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. | Q37641808 | ||
| Pneumocystis: from a doubtful unique entity to a group of highly diversified fungal species | Q37813164 | ||
| Lobomycosis: an emerging disease in humans and delphinidae | Q37994903 | ||
| Effects of Aspergillus fumigatus colonization on lung function in cystic fibrosis | Q38042346 | ||
| Azole resistance in Aspergillus fumigatus: a growing public health concern. | Q38152679 | ||
| Positive associations between respiratory outcomes and fungal index in rural inhabitants of a representative sample of French dwellings | Q40028628 | ||
| Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. | Q42230921 | ||
| High rhinovirus burden in lower airways of children with cystic fibrosis | Q42284916 | ||
| Discrimination between live and dead cellsin bacterial communities from environmental water samples analyzed by 454 pyrosequencing | Q42870897 | ||
| P921 | main subject | microbiome | Q1330402 |
| mycobiome | Q24975941 | ||
| P304 | page(s) | 89 | |
| P577 | publication date | 2015-02-13 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | The lung mycobiome: an emerging field of the human respiratory microbiome | |
| P478 | volume | 6 |
| Q61449824 | A Fungal World: Could the Gut Mycobiome Be Involved in Neurological Disease? |
| Q30234423 | Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways |
| Q28074671 | Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy |
| Q36177991 | Biotic Interactions Shape the Ecological Distributions of Staphylococcus Species |
| Q26768514 | COPD and the microbiome |
| Q51590092 | Candida albicans in cystic fibrosis: "Opening statements presented, let the trial begin". |
| Q57072800 | Characterizing the Human Mycobiota: A Comparison of Small Subunit rRNA, ITS1, ITS2, and Large Subunit rRNA Genomic Targets |
| Q62589151 | Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases |
| Q36097784 | Cytosolic phospholipase A2 contributes to innate immune defense against Candida albicans lung infection |
| Q36163849 | Data Mining of Lung Microbiota in Cystic Fibrosis Patients |
| Q36050871 | Dimensions of biodiversity in the Earth mycobiome. |
| Q57265205 | Drug Targeting of the Human Microbiome |
| Q36250078 | Ecology of the Oral Microbiome: Beyond Bacteria |
| Q50939527 | Editorial Commentary: Chronic Lung Allograft Dysfunction in Lung Transplant Recipients: Another Piece of the Puzzle |
| Q28584597 | Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation |
| Q40108783 | Fungal Pathogens in CF Airways: Leave or Treat? |
| Q47814293 | Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory. |
| Q47558222 | Fungi in Bronchiectasis: A Concise Review |
| Q54965235 | Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. |
| Q28551061 | Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation |
| Q40575597 | Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease |
| Q33752362 | Immunity against fungi |
| Q36137354 | Investigation of Pneumocystis jirovecii colonization in patients with chronic pulmonary diseases in the People's Republic of China |
| Q55479681 | Large-scale generation and analysis of filamentous fungal DNA barcodes boosts coverage for kingdom fungi and reveals thresholds for fungal species and higher taxon delimitation. |
| Q38588803 | Learning from other diseases: protection and pathology in chronic fungal infections |
| Q38920108 | Lung microbiome in human immunodeficiency virus infection |
| Q38739840 | Lung-gut cross-talk: evidence, mechanisms and implications for the mucosal inflammatory diseases. |
| Q91869803 | Metabolic phenotyping of the human microbiome |
| Q46257092 | Microbial Insights into Asthmatic Immunopathology. A Forward-Looking Synthesis and Commentary. |
| Q37739364 | Microbiome effects on immunity, health and disease in the lung |
| Q92217859 | Microfluidics-Based Enrichment and Whole-Genome Amplification Enable Strain-Level Resolution for Airway Metagenomics |
| Q37574834 | Mycobiome in the Lower Respiratory Tract - A Clinical Perspective. |
| Q52564632 | New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells. |
| Q26746024 | Next-Generation Sequencing in the Mycology Lab |
| Q46958320 | Nonsteroidal Anti-inflammatory Drugs (NSAIDS) Inhibit the Growth and Reproduction of Chaetomium globosum and Other Fungi Associated with Water-Damaged Buildings |
| Q90633294 | Optimisation and Benchmarking of Targeted Amplicon Sequencing for Mycobiome Analysis of Respiratory Specimens |
| Q37500602 | Pathogenesis of Fungal Infections in Cystic Fibrosis. |
| Q47704287 | Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes |
| Q101226448 | Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function |
| Q46848508 | Secretory IgA Deficiency in Individual Small Airways Is Associated with Persistent Inflammation and Remodeling |
| Q26865497 | Shaping the oral mycobiota: interactions of opportunistic fungi with oral bacteria and the host |
| Q40761003 | Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections |
| Q28072240 | The Eukaryotic Microbiome: Origins and Implications for Fetal and Neonatal Life |
| Q33711647 | The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment. |
| Q90094635 | The Gut-Lung Axis in Health and Respiratory Diseases: A Place for Inter-Organ and Inter-Kingdom Crosstalks |
| Q26801157 | The Impact of Immunosenescence on Pulmonary Disease |
| Q38611012 | The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review |
| Q35917770 | The Microbiome in Cystic Fibrosis |
| Q52664476 | The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis. |
| Q92611411 | The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda |
| Q39001907 | The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases |
| Q90170560 | The mycobiome of Australian tree hollows in relation to the Cryptococcus gattii and C. neoformans species complexes |
| Q38878361 | The respiratory microbiome of HIV-infected individuals |
| Q61443611 | The respiratory microbiota: new insights into pulmonary tuberculosis |
| Q39200222 | The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD. |
| Q38604173 | Update on Pediatric Cough |
| Q55489630 | Utility of serum Aspergillus-galactomannan antigen to evaluate the risk of severe acute exacerbation in chronic obstructive pulmonary disease. |
Search more.